Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
Scroll Up
Scroll Down

Colony Picking - fully automated screening of fungi
Bookmark and Share

Tecan Group Ltd.

Abengoa Bioenergy New Technologies was seeking to establish and automate a screening process to determine cellulase activity in mutant strains of cellulose producing fungi. 

The first step in the three-stage screening process was selection of colonies of different fungal mutants and their transfer to a 96-well plate to create microinocula for further fermentation. The second step involved fermentation of the different mutants in a 96-well plate format. Finally, the cellulase-producing capability of the different mutants was evaluated. 

Using these capabilities, it was possible to identify and select large fungal colonies. Successfully picking sufficient viable biomaterial from the side of the colony created microinocula with 100 % further growth efficiency for subsequent investigations. 

The automation solution shown here gave Abengoa the degree of reproducibility and efficacy required to perform their ambitious HTS program in the anticipated time frame. 

Further Information

Related Content

Tecan Academy Launched in Europe
An online training tool that makes it easier for customers to optimize their instrument use.
Wednesday, October 09, 2013
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!